Phase II study of capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer: the PANDORA trial
2023 · ESMO Open · 37 citations
https://doi.org/10.1016/j.esmoop.2023.101824
A
Alessandro Passardi
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori(IT)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
278
Papers
4.5K
Citations
33
h-index
79
i10-index
Alessandro Passardi is an academic researcher from Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Genetic factors in colorectal cancer & Cancer Immunotherapy and Biomarkers. The author has an h-index of 33, co-authored 237 publications.
ORCID: 0000-0002-7099-240XPapers by this author
worksTRIPLETE: a randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer
2018 · ESMO Open · 23 citations
https://doi.org/10.1136/esmoopen-2018-000403
Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer
2017 · Cancer Chemotherapy and Pharmacology · 19 citations
https://doi.org/10.1007/s00280-017-3279-8
Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study
2021 · ESMO Open · 17 citations
https://doi.org/10.1016/j.esmoop.2021.100073
Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience
2006 · BMC Cancer · 13 citations
https://doi.org/10.1186/1471-2407-6-76
Assessment of circulating tumor DNA in patients with locally advanced rectal cancer treated with neoadjuvant therapy
2024 · Scientific Reports · 7 citations
https://doi.org/10.1038/s41598-024-80855-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat